Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > ELEV Elevation Oncology > Detailed Quotes

ELEV Elevation Oncology

Watchlist
1.060
-0.020-1.85%
Close  02/03 16:00 ET
1.0600.0000.00%
Post Mkt Price 02/03 16:36 ET
High
1.100
Open
1.050
Turnover
9.70K
Low
1.030
Pre Close
1.080
Volume
9.03K
Market Cap
24.70M
P/E(TTM)
Loss
52wk High
5.200
Shares
23.30M
P/E(Static)
Loss
52wk Low
0.723
Float Cap
9.55M
Bid/Ask %
7.14%
Historical High
16.220
Shs Float
9.01M
Volume Ratio
0.40
Historical Low
0.723
Dividend TTM
--
Div Yield TTM
--
P/B
0.37
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.10%
Amplitude
6.46%
Avg Price
1.073
Lot Size
1
Float Cap
9.55M
Bid/Ask %
7.14%
Historical High
16.220
Shs Float
9.01M
Volume Ratio
0.40
Historical Low
0.723
Dividend TTM
--
P/B
0.37
Dividend LFY
--
Turnover Ratio
0.10%
Amplitude
6.46%
Avg Price
1.073
Lot Size
1
Price Forecast

News

Comment

Company Overview More
Elevation Oncology, Inc. operates as a precision oncology company. It focuses on the development of targeted therapeutics for the treatment of cancer in genomically-defined patient populations. The firm’s program is focused on patients with advanced solid tumors harboring an NRG1 fusion. The company was founded by Shawn M. Leland in 2019 and is headquartered in New York, NY.
CEO: Mr. Joseph J. Ferra
Market: NASDAQ
Listing Date: 06/25/2021
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist